eShowcase: TCN e-Systems
Tool places sponsors in control of their patient recruitment programs with real-time data reporting
Tool places sponsors in control of their patient recruitment programs with real-time data reporting
BBK Worldwide (Newton, MA) has a new suite of recruitment tools that are flexible and customizable for individual trial needs. TCN e-Systems produces real-time data designed to maximize clients' recruitment programs and cut enrollment times.
The main features of TCN e-Systems include: enrollment projection modeling; real-time tracking of recruitment tactics, inquiries, and referrals; accurate measurement of site and CRO performance; and control of clinical trial costs. The solution is applicable whether sponsors want to manage and/or deploy efforts for an entire therapeutic category, a specific protocol, or a single clinical study site. TCN e-Systems is comprised of six modules: Study Forecaster, Site Organizer, Patient Generator, Study Materials & Approval Tracker, Retention & Compliance, and Study Message Center.
BBK Worldwide, (617) 630-4477, www.bbkworldwide.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.
